Abstract

This work describes the characterization of plasmid-mediated quinolone-resistance (PMQR) genes from a multicenter study of ESBL-producing Enterobacteriaceae pediatric clinical isolates in Mexico. The PMQR gene-positive isolates were characterized with respect to ESBLs, and mutations in the GyrA and ParC proteins were determined. The phylogenetic relationship was established by PFGE and the transfer of PMQR genes was determined by mating assays. The prevalence of the PMQR genes was 32.1%, and the rate of qnr-positive isolates was 15.1%; 93.3% of the latter were qnrB and 6.4% were qnrA1. The distribution of isolates in terms of bacterial species was as follows: 23.5% (4/17) corresponded to E. cloacae, 13.7% (7/51) to K. pneumoniae, and 13.6% (6/44) to E. coli. In addition, the prevalence of aac(6’)-Ib-cr and qepA was 15.1% and 1.7%, respectively. The molecular characteristics of qnr- and qepA-positive isolates pointed to extended-spectrum β-lactamase (ESBL) CTX-M-15 as the most prevalent one (70.5%), and to SHV-12 in the case of aac(6’)-Ib-cr-positive isolates. GyrA mutations at codons Ser-83 and Asp-87, and ParC mutations at codons Ser-80 were observed in 41.1% and 35.2% of the qnr-positive isolates, respectively. The analysis of the transconjugants revealed a co-transmission of blaCTX-M-15 with the qnrB alleles. In general, the prevalence of PMQR genes (qnr and aac(6’)-Ib-cr) presented in this work was much lower in the pediatric isolates, in comparison to the adult isolates in Mexico. Also, ESBL CTX-M-15 was the main ESBL identified in the pediatric isolates, whereas in the adult ones, ESBLs corresponded to the CTX-M and the SHV families. In comparison with other studies, among the PMQR-genes identified in this study, the qnrB-alleles and the aac(6’)-Ib-cr gene were the most prevalent, whereas the qnrS1, qnrA1 and qnrB-like alleles were the most prevalent in China and Uruguay.

Highlights

  • The use of β-lactam antibiotics for the treatment of bacterial infections caused by Enterobacteriaceae has been and will continue to be the main line of defense against these bacterial agents

  • We carried out the characterization of plasmid-mediated quinolone resistance (PMQR) genes in ESBL-producing pediatric clinical isolates from a multicenter study in Mexico, and we identified the mutations in the gyrA and parC chromosomal genes as well as analyzed the transfer of quinolone and cephalosporin resistance genes

  • 112 ESBL-producing Enterobacteriaceae pediatric clinical isolates were collected from five hospitals in four regions of Mexico: Hospital Civil de Guadalajara (HCG) in Jalisco, in the west; Hospital de Pediatría CMN Siglo XXI (HPCMN) in Mexico City, in the center; Hospital General de Tapachula Chiapas (HGTC) in Tapachula, Chiapas and Hospital del Niño (HN) in Villahermosa, Tabasco, in the south, and Hospital Universitario (HU) in Monterrey, Nuevo León, in the north

Read more

Summary

Introduction

The use of β-lactam antibiotics for the treatment of bacterial infections caused by Enterobacteriaceae has been and will continue to be the main line of defense against these bacterial agents. Our group recently described PMQR genes in extended-spectrum β-lactamase (ESBL)-producing Enterobacteriaceae clinical isolates causing nosocomial infections in adults [12]; there are still no data regarding the pediatric population in Mexico. It is known, that quinolones should be prescribed with caution in pediatric hospitals, taking into account that arthropathy is their most worrisome side effect [13]. We carried out the characterization of PMQR genes in ESBL-producing pediatric clinical isolates from a multicenter study in Mexico, and we identified the mutations in the gyrA and parC chromosomal genes as well as analyzed the transfer of quinolone and cephalosporin resistance genes

Methods
Results
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call